Research Article
Hypovolemic Status in Older Hip Fracture Patients Elucidated by Preoperative Transthoracic Echocardiography
Table 1
Demographic characteristics of patients with hip fracture and those who underwent total hip arthroplasty (THA).
| | Hip fracture (n = 167) | THA (n = 44) | P |
| Age (year) | 87.0 (83 − 91) | 82.5 (78 − 86) | <0.01 | Female | 139 (83.2) | 35 (79.5) | 0.656 | Height (cm) | 150 (145 − 154) | 147 (140 − 153) | 0.180 | Body weight (kg) | 44.0 (39.2–51.0) | 52.1 (43.6–59.6) | <0.01 | Body surface area (m2) | 1.34 (1.26–1.46) | 1.45 (1.33–1.55) | <0.01 | Hemoglobin (g/dL) | 11.5 (10.4–12.5) | 12.8 (11.8–13.1) | <0.01 | Hematocrit (%) | 34.5 (32.0–37.9) | 38.7 (36.0–40.9) | <0.01 | Beta-blocker medication | 19 (11.4) | 5 (11.4) | 0.999 | Antiplatelet therapy | 29 (17.4) | 6 (13.6) | 0.654 | Anticoagulant therapy | 12 (7.2) | 4 (9.1) | 0.749 | Old myocardial infarction | 2 (1.2) | 1 (2.3) | 0.506 | Chronic atrial fibrillation | 10 (6.0) | 1 (2.3) | 0.466 | Maintenance hemodialysis | 0 (0.0) | 0 (0.0) | 0.999 | Pacemaker implantation | 1 (0.6) | 1 (2.3) | 0.371 | Moderate to severe AR and/or MR | 28 (16.8) | 8 (18.2) | 0.824 | Moderate to severe TR and/or PR | 34 (20.4) | 6 (13.6) | 0.390 |
|
|
AR, aortic regurgitation; MR, mitral regurgitation; TR, tricuspid regurgitation; PR, pulmonic regurgitation.
|